Guideline Title
American Gastroenterological Association medical position statement: clinical use of esophageal manometry.
Bibliographic Source(s)
Pandolfino JE, Kahrilas PJ. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology 2005 Jan;128(1):207-8. PubMed  |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: An American Gastroenterological Association medical position statement on the clinical use of esophageal manometry. American Gastroenterological Association. Gastroenterology 1994 Dec;107(6):1865.
According to the guideline developer, the Clinical Practice Committee meets three times a year to review all American Gastroenterological Association Institute (AGAI) guidelines. This review includes new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
UMLS Concepts ( what's this?)
Click to view all guideline(s) indexed with these concepts
Hide...
|
Disease/Condition(s)
Conditions for which esophageal manometry may be indicated, such as:
- Esophageal motility disorders (e.g. dysphagia or achalasia)
- Esophageal motor abnormalities
- Conditions requiring placement of intraluminal devices (e.g., pH probes)
- Conditions requiring antireflux surgery
Guideline Category
Assessment of Therapeutic Effectiveness
Diagnosis
Evaluation
Management
Clinical Specialty
Gastroenterology
Intended Users
Physicians
Guideline Objective(s)
To assist physicians in the appropriate use of esophageal manometry in patient care
Target Population
- Adults with esophageal syndromes, such as achalasia or dysphagia
- Adults being considered for antireflux surgery if uncertainty remains regarding the correct diagnosis.
- Adults requiring placement of intraluminal diagnostic devices
Interventions and Practices Considered
Major Outcomes Considered
- Utility of esophageal manometry in clinical practice
- Impact of manometry on management decisions in gastroesophageal reflux disease
- Prognostic value of manometric findings with regard to postoperative outcome in patients with esophageal motility disorders (i.e., control of reflux symptoms and incidence of symptomatic dysphagia)
|
Methods Used to Collect/Select the Evidence
Hand-searches of Published Literature (Secondary Sources)
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
The guideline developers performed a literature search for all English-language articles dealing with manometric evaluation of the esophagus from 1994 to 2003. The databases searched included MEDLINE, PreMEDLINE, and PubMed using general terms related to manometric technique (sleeve, topography) and equipment (water perfused, solid state), esophageal symptoms (dysphagia, chest pain, heartburn), esophageal disorders and procedures (gastroesophageal reflux disease, achalasia, diffuse esophageal spasm, nutcracker esophagus, hypertensive lower esophageal sphincter [LES], nonspecific motor disorders, ineffective esophageal motility, fundoplication, myotomy, dilation), and terms focused on esophageal motor function (upper esophageal sphincter, lower esophageal sphincter, esophageal body, peristalsis). Additional references were identified from references of reviewed manuscripts.
Number of Source Documents
Methods Used to Assess the Quality and Strength of the Evidence
Not stated
Rating Scheme for the Strength of the Evidence
Methods Used to Analyze the Evidence
Review
Description of the Methods Used to Analyze the Evidence
Methods Used to Formulate the Recommendations
Expert Consensus
Description of Methods Used to Formulate the Recommendations
The data used to formulate these recommendations are derived from the data available at the time of their creation. Ideally, the intent is to provide evidence based upon prospective, randomized, placebo-controlled trials; however, when this is not possible the use of experts' consensus may occur.
Rating Scheme for the Strength of the Recommendations
Cost Analysis
Guideline developers reviewed published cost analyses.
Method of Guideline Validation
External Peer Review
Description of Method of Guideline Validation
The document was approved by the American Gastroenterological Association Clinical Practice Committee on October 2, 2004, and by the American Gastroenterological Association Governing Board on November 7, 2004.
|
Major Recommendations
These recommendations are an update from previous recommendations published in 1994 and represent the results of meticulous research into areas of controversy from the previous policy statement. In addition, new techniques have evolved that may improve and complement manometric diagnosis. Thus, these recommendations also take into account how these new technologies may alter clinical practice.
Indications for Esophageal Manometry
- Manometry is indicated to establish the diagnosis of dysphagia in instances in which a mechanical obstruction (e.g., stricture) cannot be found. This is particularly important if a diagnosis of achalasia is suspected. However, given the low prevalence of achalasia in patients with esophageal symptoms, more common esophageal disorders should be excluded with barium radiographs or endoscopy before manometric evaluation.
- Manometric techniques are indicated for placement of intraluminal devices (e.g., pH probes) when positioning is dependent on the relationship to functional landmarks, such as the lower esophageal sphincter.
- Manometry is indicated for the preoperative assessment of patients being considered for antireflux surgery if there is any question of an alternative diagnosis, especially achalasia.
Possible Indications for Esophageal Manometry
- Manometry is possibly indicated for the preoperative assessment of peristaltic function in patients being considered for antireflex surgery.
- Manometry is possibly indicated to assess symptoms of dysphagia in patients who have undergone either antireflux surgery or treatment for achalasia.
Esophageal Manometry Not Indicated
- Manometry is not indicated for making or confirming a suspected diagnosis of gastroesophageal reflux disease.
- Manometry should not be routinely used as the initial test for chest pain or other esophageal symptoms because of the low specificity of the findings and the low likelihood of detecting a clinically significant motility disorder.
|
Evidence Supporting the Recommendations
Type of Evidence Supporting the Recommendations
The type of evidence supporting the recommendations is not specifically stated.
The recommendations are based upon the interpretation and assimilation of scientifically valid research, derived from a comprehensive review of published literature.
|
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
Appropriate clinical use of esophageal manometry
|
Qualifying Statements
The Medical Position Statements (MPS), developed under the aegis of the American Gastroenterological Association (AGA) and its Clinical Practice Committee (CPC), were approved by the AGA Governing Board. The data used to formulate these recommendations are derived from the data available at the time of their creation and may be supplemented and updated as new information is assimilated. These recommendations are intended for adult patients, with the intent of suggesting preferred approaches to specific medical issues or problems. They are based upon the interpretation and assimilation of scientifically valid research, derived from a comprehensive review of published literature. Ideally, the intent is to provide evidence based upon prospective, randomized, placebo-controlled trials; however, when this is not possible the use of experts' consensus may occur. The recommendations are intended to apply to healthcare providers of all specialties. It is important to stress that these recommendations should not be construed as a standard of care. The AGA stresses that the final decision regarding the care of the patient should be made by the physician with a focus on all aspects of the patient's current medical situation.
|
Implementation of the Guideline
Description of Implementation Strategy
An implementation strategy was not provided.
|
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Getting Better
Living with Illness
|
Identifying Information and Availability
Bibliographic Source(s)
Pandolfino JE, Kahrilas PJ. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology 2005 Jan;128(1):207-8. PubMed  |
Adaptation
Not applicable: The guideline was not adapted from another source.
Date Released
1994 Jul 15 (revised 2005 Jan)
Guideline Developer(s)
American Gastroenterological Association Institute - Medical Specialty Society
Source(s) of Funding
American Gastroenterological Association Institute
Guideline Committee
American Gastroenterological Association Clinical Practice Committee
Composition of Group That Authored the Guideline
Authors: John E. Pandolfino; Peter J. Kahrilas
Financial Disclosures/Conflicts of Interest
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: An American Gastroenterological Association medical position statement on the clinical use of esophageal manometry. American Gastroenterological Association. Gastroenterology 1994 Dec;107(6):1865.
According to the guideline developer, the Clinical Practice Committee meets three times a year to review all American Gastroenterological Association Institute (AGAI) guidelines. This review includes new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.
Availability of Companion Documents
The following is available:
- American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology 2005 Jan;128(1);209-24.
Electronic copies: Available from the American Gastroenterological Association Institute (AGAI) Web site .
Print copies: Available from American Gastroenterological Association Institute, 4930 Del Ray Avenue, Bethesda, MD 20814.
NGC Status
This summary was completed by ECRI on June 30, 1998. It was verified by the guideline developer on December 1, 1998. This NGC summary was updated by ECRI on January 31, 2005.
Copyright Statement
This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Public Policy Coordinator, American Gastroenterological Association, 4930 Del Ray Avenue, Bethesda, MD 20814; telephone, (301) 654-2055; fax, (301) 654-5970.
|
NGC Disclaimer
The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. Read full disclaimer...The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.
All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.
Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.
NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.
Readers with questions regarding guideline content are directed to contact the guideline developer. Hide...
|